Skip to main navigationSkip to main content
The University of Southampton

Dr Maria Chorozoglou BSc (Honours) Economics, MSc Health Economics & Modelling

Senior Health Economist part of the SHTAC Health Economics team

Dr Maria Chorozoglou's photo

Dr Maria Chorozoglou is Senior Health Economist part of the SHTAC Health Economics team within Medicine at the University of Southampton.

Maria is a member of the Faculty of Medicine at the University of Southampton since 2008. She joined SHTAC in November 2014, as a member of the Health Economics team. SHTAC assesses the clinical and cost-effectiveness of health technologies for NICE and the NIHR, as one of the nine academic teams in the UK contracted by the Department of Health. Prior to her current position, she has been a member of the Wessex Institute and later of Primary Care and Population Sciences, participating in clinical studies as the named health economist and providing support and advice to clinical teams through the Southampton Research Design Service (RDS SC) and the Southampton Biomedical Research Unit (nee BRU), from 2010 to 2013.

Her current work includes: (i) contributing in Technology Assessment Reports (TAR) for the National Institute for Health and Care Excellence (NICE), and (ii) participating as co-investigator in clinical trials and studies, and further developing and expanding a portfolio of primary research studies.

Her TAR projects currently include assessing drugs to treat juvenile idiopathic arthritis and drugs to treat chronic hepatitis C.

Her primary research portfolio mainly includes studies for children funded by NIHR (Programme Grants for Applied Research, Health Technology Assessment, and Research for Patient Benefit) and Wellcome Trust. Maria has experience conducting economic evaluations alongside clinical trials, cross-sectional/longitudinal studies and individual/cohort modelling techniques. Her research interests lie in methodological issues of the economics of paediatric health, focusing on the analysis of long-term economic implications of chronic disease, physical impairment and mental health.

Prior to joining the academia Maria had a long standing career in industry; she holds an MBA and a specialisation diploma in forecasting business economic magnitudes from The National and Capodistrian University of Athens. She also holds a license as consultant economist from The Economic Chamber of Greece.

UK qualifications:

BSc (Hons) Economics,

MSc Health Economics and Decision Modelling, ScHARR Scholarship/University of Sheffield

Research interests

  • Methodological aspects of health technology assessment in paediatric and early life interventions, incorporating long term economic implications,
  • Quality of life measurement in very young children for economic evaluation and health technology assessment

Current work includes exploring methodological approaches and risk assessment of integrating observational data in economic analyses.

Recently completed methodological work includes assessment of preference-based quality of life measures, employed within the Health Technology Assessment (HTA) and Quality Adjusted Life Year (QALY) framework for children less than 5 years old.

Research projects

Current TAR projects:

(1) Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis – Multiple Technology Appraisal (MTA)/Technology Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Care Excellence.

(2) Ombitasvir/paritaprevir/ritonavir with or without dasabuvir for treating chronic hepatitis C – Single Technology Appraisal (STA)/ Evidence Review Group Report commissioned by the NIHR HTA Programme on behalf of NICE.

Current Primary Research Projects:

(1) Effect of early intervention for permanent childhood hearing impairment on outcome at secondary school age “HOT”, Wellcome Trust, 01/01/2010 - 17/05/2014, health economist.

(2) The development of an integrated early detection and intervention model for ADHD “PEDIA/COPPI”, NIHR/PGfAR, 1/12/2009 - 31/03/2015, health economist.

(3) Bath additives for the treatment of childhood eczema “BATHE”, NIHR/HTA, 01/05/2014 – 31/10/2017, co-applicant and health economist.

(4) Prevention of morbidity in sickle cell disease “POMS”, NIHR/RfPB, 01/10/2013 – 30/09/2015, co-applicant and health economist.

Recently delivered primary research projects:

(1) Development of an integrated service model incorporating innovative technology for the rehabilitation of the upper limb following stroke “ATRAS”, NIHR/PGfAR, 2010-13, health economist.

(2) Supporting parents and carers’ management of childhood eczema “SPaCE”, NIHR/RfPB, 2013, health economist.

(3) A qualitative study of mindfulness based stress reduction for the treatment of fatigue, anxiety and depression in women with metastatic breast cancer “MFAB”, NIHR/RfPB, 2013, health economist.

Research group


Maria provides health economics support to clinical trials and the development of grant applications.

Sort via:TypeorYear




Dr Maria Chorozoglou
Southampton Health Technology Assessment Centre (SHTAC), Faculty of Medicine/University of Southampton Epsilon House, Enterprise Road The University of Southampton Science Park Southampton SO16 7NS

Follow us on Twitter: @SHTAC_uni_soton
SHTAC is part of the Wessex Institute, Faculty of Medicine.

Room Number: 97 Chilwth Eps/2005

Share this profile Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings